ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989

60 Minutes Report “Deception at Duke” Wins Peabody Award

March 29, 2013